Pulmonary embolism is a common, potentially fatal condition, so accurate and rapid diagnosis is essential. The purpose of this study was to evaluate perfusion-ventilation lung scans, using the relevant radiopharmaceuticals 99mTc-MAA and radioaerosols, as a non-invasive and accessible method with acceptable sensitivity and specificity for diagnosing pulmonary embolism.
Materials and methods: In this study, 149 patients presenting with respiratory complaints were evaluated. Perfusion scan images were obtained following intravenous injection of 99mTc-MAA, and ventilation scans following inhalation of 99mTc-DTPA aerosol, in standard views; the scans were then assessed by a nuclear medicine specialist for the probability of pulmonary embolism. The relationship between sex, age, clinical presentation, presence of risk factors, history of cardiopulmonary disease, and chest radiograph findings, and the probability (high vs. low) of pulmonary embolism, was evaluated. The study included 78 men and 71 women, all assessed after history-taking, chart review, and review of accompanying records.
Findings: The proportion of men with pulmonary embolism was statistically higher than women (P<0.005); the highest disease prevalence was seen in patients over 50 years of age (P=0.005); and the presence of clinical manifestations showed a direct relationship with the probability of pulmonary embolism (P=0.005). A history of cardiopulmonary disease, an abnormal chest radiograph, and absence of risk factors were all associated with a low probability of pulmonary embolism; however, the presence or absence of risk factors did not show a statistically significant difference with respect to high probability of pulmonary embolism (P=0.232).
Conclusion: Perfusion-ventilation lung scanning is recommended as an acceptable method for the initial diagnosis of pulmonary embolism and for evaluating its prevalence and contributing factors.

